Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127086001 | 12708600 | 1 | I | 20160829 | 20160901 | 20160901 | EXP | US-PFIZER INC-2016409335 | PFIZER | 35.00 | YR | M | Y | 0.00000 | 20160901 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127086001 | 12708600 | 1 | PS | DAPTOMYCIN. | DAPTOMYCIN | 1 | UNK | N | 202857 | POWDER FOR INJECTION | |||||||||
| 127086001 | 12708600 | 2 | SS | MEROPENEM. | MEROPENEM | 1 | UNK | U | 90940 | ||||||||||
| 127086001 | 12708600 | 3 | SS | CRESEMBA | ISAVUCONAZONIUM SULFATE | 1 | Intravenous (not otherwise specified) | UNK | 0 | INJECTION | |||||||||
| 127086001 | 12708600 | 4 | SS | AMBISOME | AMPHOTERICIN B | 1 | UNK | N | 0 | INJECTION | |||||||||
| 127086001 | 12708600 | 5 | SS | TELAVANCIN | TELAVANCIN | 1 | UNK | U | 0 | ||||||||||
| 127086001 | 12708600 | 6 | SS | POLYMYXIN B. | POLYMYXIN B | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127086001 | 12708600 | 1 | Fungal infection |
| 127086001 | 12708600 | 2 | Fungal infection |
| 127086001 | 12708600 | 3 | Fungal infection |
| 127086001 | 12708600 | 4 | Fungal infection |
| 127086001 | 12708600 | 5 | Fungal infection |
| 127086001 | 12708600 | 6 | Fungal infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127086001 | 12708600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127086001 | 12708600 | Blood creatine phosphokinase increased | |
| 127086001 | 12708600 | Product use issue | |
| 127086001 | 12708600 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127086001 | 12708600 | 3 | 20160720 | 0 |